David Natan - 07 Jan 2026 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role: Director
Signature: /s/ David Natan
Issuer symbol: INDP
Transactions as of: 07 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 22 Jan 2026, 21:56:24 UTC
Previous filing: 09 Jan 2026
Next filing: 12 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
NATAN DAVID	Director	C/O INDAPTUS THERAPEUTICS, INC., 3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK	/s/ David Natan	22 Jan 2026	0001253108

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INDP	Option to Buy Common Stock	Award	$0	+25,000		$0.000000	25,000	07 Jan 2026	Common Stock	25,000	$2.69	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person acquired options to purchase 25,000 shares of common stock pursuant to the Issuer's non-employee director compensation program. The stock options vest over three years commencing from the date of grant in equal quarterly installments subject to continued service on the Issuer's board of directors through each vesting date.